CORD-19:775b90287b44353bee979abb0970a4666022f86d / 292893-293027 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"Subjects were treated with AB MDPI or AB HFA (90 mg/inhalation) and respective placebo in a randomized-sequence, two-period crossover.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T85032","span":{"begin":0,"end":134},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T85032","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T180","span":{"begin":0,"end":134},"obj":"Sentence"}],"attributes":[{"subj":"T180","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1857","span":{"begin":41,"end":44},"obj":"Disease"},{"id":"T44679","span":{"begin":41,"end":44},"obj":"Disease"}],"attributes":[{"id":"A1857","pred":"mondo_id","subj":"T1857","obj":"http://purl.obolibrary.org/obo/MONDO_0007710"},{"id":"A49318","pred":"mondo_id","subj":"T44679","obj":"http://purl.obolibrary.org/obo/MONDO_0007710"},{"subj":"T1857","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T44679","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#afec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec93c9"},{"id":"CORD-19-PD-MONDO","color":"#93e3ec"}]}]}}